Prostate cancer imaging.

Abstract

As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. Magnetic resonance imaging (MRI) may enhance the staging of prostate cancer compared with clinical evaluation, transrectal ultrasound, or computed tomography (CT), and allows concurrent evaluation of prostatic, periprostatic, and pelvic anatomy. In clinical practice, the fusion of MRI or dynamic contrast-enhanced MRI (DCE-MRI) with MR spectroscopic imaging (MRSI) is improving the evaluation of cancer location, size, and extent, while providing an indication of tumor aggressiveness. Pretreatment knowledge of these prognostic variables is essential for achieving minimally invasive, patient-specific therapy.

DOI: 10.1080/02841850701545821
0500100015002008200920102011201220132014201520162017
Citations per Year

2,688 Citations

Semantic Scholar estimates that this publication has 2,688 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Fuchsjger2008ProstateCI, title={Prostate cancer imaging.}, author={Michael Fuchsj{\"a}ger and Amita Shukla-Dave and Oguz Akin and Jelle O. Barentsz and Hedvig Hricak}, journal={Acta radiologica}, year={2008}, volume={49 1}, pages={107-20} }